$27M funding to Focus on the Future of Biomanufacturing
Dr. Stefano Menegatti and Dr. Ruben Carbonell will lead a new 5-year project funded by the Novo Nordisk Foundation. The project, “Accelerated Innovation in Manufacturing Biologics (AIM-Bio),” focuses on the developing nine new novel technologies of biopharmaceutical manufacturing including: cell factory engineering, bioreactor designs and optimization of purification of biopharmaceutical products. NC State will receive $18 million to carry out its research, and the remainder will go to Technical University of Denmark (DTU). To read more about the project click here.
